Unknown

Dataset Information

0

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma.


ABSTRACT:

Purpose

In this prospective exploratory study, we evaluated the feasibility of [18F]fluorodeoxyglucose ([18F]FDG) PET/MRI-based chemotherapy response prediction in pancreatic ductal adenocarcinoma at two weeks upon therapy onset.

Material and methods

In a mixed cohort, seventeen patients treated with chemotherapy in neoadjuvant or palliative intent were enrolled. All patients were imaged by [18F]FDG PET/MRI before and two weeks after onset of chemotherapy. Response per RECIST1.1 was then assessed at 3 months [18F]FDG PET/MRI-derived parameters (MTV50%, TLG50%, MTV2.5, TLG2.5, SUVmax, SUVpeak, ADCmax, ADCmean and ADCmin) were assessed, using multiple t-test, Man-Whitney-U test and Fisher's exact test for binary features.

Results

At 72 ± 43 days, twelve patients were classified as responders and five patients as non-responders. An increase in ∆MTV50% and ∆ADC (≥ 20% and 15%, respectively) and a decrease in ∆TLG50% (≤ 20%) at 2 weeks after chemotherapy onset enabled prediction of responders and non-responders, respectively. Parameter combinations (∆TLG50% and ∆ADCmax or ∆MTV50% and ∆ADCmax) further improved discrimination.

Conclusion

Multiparametric [18F]FDG PET/MRI-derived parameters, in particular indicators of a change in tumor glycolysis and cellularity, may enable very early chemotherapy response prediction. Further prospective studies in larger patient cohorts are recommended to their clinical impact.

SUBMITTER: Harder FN 

PROVIDER: S-EPMC8319249 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>In this prospective exploratory study, we evaluated the feasibility of [<sup>18</sup>F]fluorodeoxyglucose ([<sup>18</sup>F]FDG) PET/MRI-based chemotherapy response prediction in pancreatic ductal adenocarcinoma at two weeks upon therapy onset.<h4>Material and methods</h4>In a mixed cohort, seventeen patients treated with chemotherapy in neoadjuvant or palliative intent were enrolled. All patients were imaged by [<sup>18</sup>F]FDG PET/MRI before and two weeks after onset of chemo  ...[more]

Similar Datasets

| S-EPMC7907291 | biostudies-literature
| S-EPMC10212867 | biostudies-literature
| S-EPMC6681694 | biostudies-literature
| S-EPMC10040668 | biostudies-literature
| S-EPMC11634952 | biostudies-literature
| S-EPMC9433207 | biostudies-literature
| S-EPMC6419652 | biostudies-literature
| S-EPMC10561067 | biostudies-literature
| S-EPMC7431424 | biostudies-literature
| S-EPMC11214925 | biostudies-literature